XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Dec. 31, 2023
Jun. 30, 2023
Current assets:    
Cash and cash equivalents $ 19,529 $ 22,985
Accounts receivable, net 29,403 28,937
Inventories 13,001 11,995
Prepaid expenses 8,105 8,047
Other current assets 1,333 868
Total current assets 71,371 72,832
Non-current assets:    
Property and equipment, net 1,127 1,815
Operating lease right-of-use assets [1] 2,133 2,054
Intangible assets, net 55,711 58,970
Other non-current assets 907 792
Total non-current assets 59,878 63,631
Total assets 131,249 136,463
Current liabilities:    
Accounts payable 10,473 13,478
Accrued liabilities 43,413 46,799
Short-term line of credit 1,026 1,563
Current portion of debt 39 85
Other current liabilities 9,236 7,090
Total current liabilities 64,187 69,015
Non-current liabilities:    
Debt, net of current portion 14,978 14,713
Derivative warrant liabilities 12,887 6,403
Other non-current liabilities 6,344 6,975
Total non-current liabilities 34,209 28,091
Commitments and contingencies (note 13)
Stockholders’ equity:    
Preferred stock, par value $.0001; 50,000,000 shares authorized; no shares issued or outstanding 0 0
Common stock, par value $.0001; 200,000,000 shares authorized; 5,567,347 and 5,517,174 shares issued and outstanding, respectively 1 1
Additional paid-in capital 345,321 343,485
Accumulated deficit (312,469) (304,129)
Total stockholders’ equity 32,853 39,357
Total liabilities and stockholders’ equity $ 131,249 $ 136,463
[1] Includes $0.2 million from the Consumer Health Segment as of December 31, 2023 and June 30, 2023.